Sen. Thom Tillis (R-NC) (J. Scott Applewhite/AP Images)

Phar­ma-friend­ly sen­a­tor calls on FDA for a third time to show patent pro­tec­tions should­n't be blamed for high drug prices

North Car­oli­na Re­pub­li­can Sen. Thom Tillis made a name for him­self in the 2020 elec­tion cy­cle as the dar­ling of the phar­ma in­dus­try, ac­cept­ing hun­dreds of thou­sands in cam­paign con­tri­bu­tions, even from the likes of Pfiz­er CEO Al­bert Bourla.

Those con­tri­bu­tions have led Tillis to at­tempt to re-write patent laws in phar­ma’s fa­vor, a move which failed to gain steam in 2019, and re­quest for a third time since Jan­u­ary that the FDA should help stop “the false nar­ra­tive that patent pro­tec­tions are to blame for high drug prices.”

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.